KingMed Diagnostics (Hong Kong) Limited announced a private placement of common shares for gross proceeds of CNY 30 million on July 6, 2020. The transaction participation from existing investor Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882). The transaction has approved by investor's board of director at 15th session of the 2nd directorate meeting. Post teh transaction, the registered capital of the company will be CNY 105,832,500.
On July 3, 2020, the Issuance Review Committee of China Securities Regulatory Commission approved the application in respect to the transaction.